Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Accor, BioMerieux, EDF, Lafarge, Virbac: French Equity Preview

The following is a list of companies whose stocks may have unusual price changes in Paris. Symbols are in parentheses after company names and prices are from the last close.

France’s CAC 40 Index fell 0.9 percent to 3,976.71, while the broader SBF120 Index declined 0.9 percent.

Accor SA (AC FP): Europe’s largest lodging company said 2010 revenue rose to 5.95 billion euros ($8.02 billion), from 5.49 billion euros a year earlier, and raised its 2010 operating profit forecast to 440 million euros. The shares fell 0.9 percent to 34.67 euros.

Alstom SA (ALO FP): The world’s third-largest maker of power equipment said third-quarter sales reached 5.2 billion euros, less than the 5.3 billion euros forecast by analysts polled by Bloomberg. The stock dropped 1.9 percent to 39.86 euros.

BioMerieux SA (BIM FP): The maker of HIV and hepatitis tests said fourth-quarter revenue rose to 373.4 million euros from 328 million euros. The shares fell 0.7 percent to 74.50 euros.

Danone SA (BN FP): The world’s biggest maker of yoghurt was cut to “neutral” from “outperform” at Exane BNP Paribas. The shares declined 0.8 percent to 44.72 euros.

EDF SA (EDF FP): France’s largest utility entered an agreement with Alstom (ALO FP) to participate in a government tender for domestic offshore wind projects. EDF fell 0.9 percent to 32.25 euros. Alstom dropped 1.9 percent to 39.86 euros.

Lafarge SA (LG FP): Europe’s most indebted cement producer is drawing interest from buyout firms for its gypsum business, four people familiar with the situation said. The shares rose 0.6 percent to 47.3 euros.

Virbac SA (VIRP FP): The manufacturer of veterinary medicines said 2010 revenue rose to 572.5 million euros from 467.4 million euros. The shares fell 3.3 percent to 111.45 euros.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.